Inflammatory mediators and cytokine signaling pathways

Inflammatory mediators and cytokine signaling pathways represent the complex biochemical networks responsible for initiating and regulating immune responses (StatPearls, 2023). These pathways involve a diverse array of molecules, including cytokines such as tumor necrosis factor-alpha and interleukin-6, chemokines, and lipid mediators like prostaglandins, which act as primary signals for cell-to-cell communication during injury or infection (NCBI, 2022). Upon binding to their respective receptors, these mediators activate intracellular signaling cascades such as the Janus kinase-signal transducer and activator of transcription (JAK-STAT), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), and mitogen-activated protein kinase (MAPK) pathways, leading to the transcription of genes involved in cell recruitment and activation (Nature Reviews Immunology, 2019). Chronic overactivation of these pathways is a hallmark of numerous pathologies, including rheumatoid arthritis, inflammatory bowel disease, and the severe 'cytokine storms' seen in viral infections. Pharmacological modulation of these pathways is a cornerstone of modern medicine, utilizing monoclonal antibodies to neutralize ligands or small molecules to inhibit downstream kinases. However, therapeutic targeting must balance the need to suppress pathological inflammation with the necessity of maintaining functional host defense mechanisms (PubMed, 2021).

Other names

Inflammatory signaling cascadesCytokine-mediated signalingPro-inflammatory pathwaysInflammatory signaling network

The mechanism of action involves the inhibition of pro-inflammatory signaling at various levels: neutralization of circulating ligands (e.g., anti-tumor necrosis factor antibodies), competitive antagonism of cell-surface receptors (e.g., interleukin-1 receptor antagonists), or the inhibition of intracellular signal transduction enzymes like Janus kinases (JAK inhibitors) to prevent gene expression (StatPearls, 2023; Nature Reviews Immunology, 2019).